Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS)
CNY 8.87
(2.31%)
CNY 8.87
(2.31%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 184.87 Million CNY | 18.4% |
| 2022 | 156.15 Million CNY | 36.65% |
| 2021 | 114.26 Million CNY | 29.76% |
| 2020 | 88.06 Million CNY | 34.14% |
| 2019 | 65.65 Million CNY | -3.18% |
| 2018 | 67.8 Million CNY | -2.1% |
| 2017 | 69.26 Million CNY | 125.36% |
| 2016 | 30.73 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 244.63 Million CNY | 15.95% |
| 2024 Q1 | 191.71 Million CNY | 3.7% |
| 2024 Q2 | 210.98 Million CNY | 10.05% |
| 2023 Q3 | 192.04 Million CNY | 11.4% |
| 2023 Q4 | 184.87 Million CNY | -3.73% |
| 2023 FY | 184.87 Million CNY | 18.4% |
| 2023 Q1 | 162.33 Million CNY | 3.96% |
| 2023 Q2 | 172.38 Million CNY | 6.19% |
| 2022 Q4 | 156.15 Million CNY | -9.45% |
| 2022 Q3 | 172.43 Million CNY | 9.03% |
| 2022 Q2 | 158.16 Million CNY | 6.6% |
| 2022 FY | 156.15 Million CNY | 36.65% |
| 2022 Q1 | 148.37 Million CNY | 29.84% |
| 2021 Q4 | 114.26 Million CNY | -5.29% |
| 2021 Q3 | 120.64 Million CNY | 5.88% |
| 2021 Q2 | 113.94 Million CNY | 24.87% |
| 2021 Q1 | 91.25 Million CNY | 3.62% |
| 2021 FY | 114.26 Million CNY | 29.76% |
| 2020 Q2 | 71.45 Million CNY | -2.49% |
| 2020 FY | 88.06 Million CNY | 34.14% |
| 2020 Q4 | 88.06 Million CNY | 11.86% |
| 2020 Q3 | 78.72 Million CNY | 10.18% |
| 2020 Q1 | 73.27 Million CNY | 11.61% |
| 2019 Q4 | 65.65 Million CNY | 0.0% |
| 2019 FY | 65.65 Million CNY | -3.18% |
| 2019 Q2 | 64.96 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 67.8 Million CNY | -2.1% |
| 2017 FY | 69.26 Million CNY | 125.36% |
| 2016 FY | 30.73 Million CNY | 0.0% |